To gain further insight into the role of SMYD3 in cancer-related epigenetic processes, we investigated in depth the interaction between SMYD3 and specific P-proteins involved in the emerging ‘nonmutational epigenetic reprogramming’ cancer hallmark (Fig. 2). Here, OCA2 is linked to cancer.